蛋白激酶STK24通过AKT-PD-L1轴促进瘤的免疫逃避
Ning Wang1, Yu Jiang2, Mengjie Li1
1Institute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 16, 2024
概括
瘤细胞中的STK24缺乏通过增强CD8+T细胞活性来增强抗PD-1免疫疗法. 抑制STK24有望克服瘤对免疫疗法的抵抗性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 针对PD-L1的免疫疗法在许多瘤中显示出可变的疗效.
- 克服治疗耐药性需要结合免疫疗法策略.
- 目前尚不完全了解STK24在瘤免疫中的作用.
研究的目的:
- 调查胺-氨酸激酶24 (STK24) 在瘤生长和抗PD-1治疗反应中的作用.
- 阐明STK24影响抗瘤免疫力的机制.
- 评估STK24作为组合免疫治疗的潜在治疗标.
主要方法:
- 利用小鼠合成模型来评估STK24缺乏的瘤生长.
- 研究了STK24与AKT的相互作用及其对PD-L1表达的影响.
- 在患者瘤样本中分析了STK24水平.
- 在体内评估了STK24抑制与抗PD-1阻断相结合的疗效.
主要成果:
- STK24缺乏通过增强细胞毒性CD8+ T和NK细胞活性,显著减弱瘤生长.
- 在Thr21处,STK24直接酸化AKT,促进AKT的激活和PD-L1的诱导.
- STK24抑制阻断了IFN-γ介导的PD-L1表达,并增强了抗PD-1疗法的疗效.
- 患者中STK24水平升高与CD8+T细胞透率降低和生存率降低相关.
结论:
- STK24是抗瘤免疫的关键调节者,调节AKT和PD-L1/PD-1信号传递.
- STK24缺乏症可以提高抗PD-1免疫疗法的疗效.
- STK24代表了结合免疫治疗策略的有希望的新目标,以克服瘤耐药性.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


